1286 related articles for article (PubMed ID: 11849452)
1. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
[TBL] [Abstract][Full Text] [Related]
2. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Parker WR; Asplin JR
Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
[TBL] [Abstract][Full Text] [Related]
3. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Asplin JR
J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
[TBL] [Abstract][Full Text] [Related]
4. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Grynpas MD; Asplin JR
Kidney Int; 2001 Apr; 59(4):1415-23. PubMed ID: 11260403
[TBL] [Abstract][Full Text] [Related]
5. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats.
Evan AP; Bledsoe SB; Smith SB; Bushinsky DA
Kidney Int; 2004 Jan; 65(1):154-61. PubMed ID: 14675046
[TBL] [Abstract][Full Text] [Related]
6. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
[TBL] [Abstract][Full Text] [Related]
7. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Laplante K; Asplin JR
Kidney Int; 2006 May; 69(9):1586-92. PubMed ID: 16557225
[TBL] [Abstract][Full Text] [Related]
8. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
[TBL] [Abstract][Full Text] [Related]
9. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
10. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
11. Magnesium decreases urine supersaturation but not calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
Li Q; Krieger NS; Yang L; Asplin J; Bushinsky DA
Nephron; 2024 Jan; ():. PubMed ID: 38262368
[TBL] [Abstract][Full Text] [Related]
12. Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones.
Messa P; Marangella M; Paganin L; Codardini M; Cruciatti A; Turrin D; Filiberto Z; Mioni G
Clin Sci (Lond); 1997 Sep; 93(3):257-63. PubMed ID: 9337641
[TBL] [Abstract][Full Text] [Related]
13. Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats.
Bushinsky DA; Michalenka AC; Strutz KL; Donahue S; Asplin JR
Kidney Int; 2008 Feb; 73(4):423-9. PubMed ID: 18046318
[TBL] [Abstract][Full Text] [Related]
14. Stone formation in genetic hypercalciuric rats.
Bushinsky DA; Grynpas MD; Nilsson EL; Nakagawa Y; Coe FL
Kidney Int; 1995 Dec; 48(6):1705-13. PubMed ID: 8587230
[TBL] [Abstract][Full Text] [Related]
15. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
16. Dietary oxalate and calcium oxalate nephrolithiasis.
Khan SR; Glenton PA; Byer KJ
J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
[TBL] [Abstract][Full Text] [Related]
17. Divergence between stone composition and urine supersaturation: clinical and laboratory implications.
Lingeman J; Kahnoski R; Mardis H; Goldfarb DS; Grasso M; Lacy S; Scheinman SJ; Asplin JR; Parks JH; Coe FL
J Urol; 1999 Apr; 161(4):1077-81. PubMed ID: 10081841
[TBL] [Abstract][Full Text] [Related]
18. The relation between bone and stone formation.
Krieger NS; Bushinsky DA
Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
Schwille PO; Schmiedl A; Wipplinger J
Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
[TBL] [Abstract][Full Text] [Related]
20. Chlorthalidone with potassium citrate decreases calcium oxalate stones and increases bone quality in genetic hypercalciuric stone-forming rats.
Krieger NS; Asplin J; Granja I; Chen L; Spataru D; Wu TT; Grynpas M; Bushinsky DA
Kidney Int; 2021 May; 99(5):1118-1126. PubMed ID: 33417997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
